Wren Therapeutics
110
Volume
+1900%
Growth
exploding
About the Topic
Biopharmaceutical company focused on drug discovery and development for protein misfolding diseases. Wren Therapeutics targets transient, unstable protein intermediates in amyloid disease pathways, specifically toxic oligomers, with small-molecule therapeutics, aiming to address diseases characterized by protein misfolding and aggregation, such as Alzheimer's disease. The company's work primarily benefits patients suffering from neurodegenerative diseases and other conditions related to protein misfolding.
Wren Therapeutics was discovered on August 18th 2021 and it currently has a search volume of 110 with a growth of +1900%.
Key Indicators
Growth
- Exploding
- Regular
- Peaked
Speed
- Exponential
- Constant
- Stationary
Seasonality
- High
- Medium
- Low
Volatility
- High
- Average
- Low
Members Only
Try Exploding Topics Pro
Get Free, Unlimited Access for 7 Days.
Categories
Save this topic and build your own trend dashboard.
Available with Exploding Topics Pro, try it now.
1.1M+ trends in our growing database.